Jim Simons Enveric Biosciences, Inc. Transaction History

Renaissance Technologies LLC

  • $56.7 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$8.8 - $16.2 $7.91 Million - $14.6 Million
-898,502 Reduced 45.14%
1,092,098 $234,000
Q1 2022

May 13, 2022
BUY
$12.5 - $52.0 $18 Million - $74.7 Million
1,436,500 Added 259.25%
1,990,600 $657,000
Q4 2021

Feb 11, 2022
BUY
$46.5 - $104.0 $2.86 Million - $6.4 Million
61,547 Added 12.5%
554,100 $515,000
Q3 2021

Nov 12, 2021
BUY
$80.5 - $175.0 $39.7 Million - $86.2 Million
492,553 New
492,553 $1.02 Million

About Enveric Biosciences, Inc.

ENVB Quotes by TradingView
  • Ticker ENVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,078,270
  • Market Cap $1.04M
  • Description
  • Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for...
More about ENVB
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email